Elizabeth O’Donnell
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 57
- Multiple Myeloma Research and Treatments 56
- Oncology 48
- CAR-T cell therapy research 14
- Peptidase Inhibition and Analysis 11
- Cancer Treatment and Pharmacology 10
- Co-authors
- Noopur RajeL. V. B. NicholsonAndrew J. YeeAri SadanandomClarke R. SlaterGavin FalkousLucio ContiPeter Dominy
- Journals
- Blood (23 papers)Journal of Clinical Oncology (20 papers)Blood Advances (5 papers)Annals of Oncology (4 papers)British Journal of Haematology (3 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Elizabeth O’Donnell
106 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 110
- Hematology 636
- Oncology 815
- Genetics 218
- Biological Psychiatry 50
- Molecular Biology 1.2k
Countries citing papers authored by Elizabeth O’Donnell
This map shows the geographic impact of Elizabeth O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth O’Donnell more than expected).
Fields of papers citing papers by Elizabeth O’Donnell
This network shows the impact of papers produced by Elizabeth O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth O’Donnell. The network helps show where Elizabeth O’Donnell may publish in the future.
Co-authors
The 25 scholars most cited alongside Elizabeth O’Donnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 17 | |
| 11 | 2023 | 2 | |
| 12 | 2021 | 23 | |
| 13 | 2021 | 27 | |
| 14 | 2020 | 17 | |
| 15 | 2020 | 80 | |
| 16 | 2018 | 3 | |
| 17 | 2018 | 14 | |
| 18 | 2017 | 8 | |
| 19 | 2008 | 158 | |
| 20 | 1986 | 6 |
About Elizabeth O’Donnell
Elizabeth O’Donnell is a scholar working on Hematology, Oncology, Genetics, Reproductive Medicine and Molecular Biology, having authored 116 papers that have together received 2.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (56 papers), Protein Degradation and Inhibitors (21 papers), Testicular diseases and treatments (15 papers), CAR-T cell therapy research (14 papers), Peptidase Inhibition and Analysis (11 papers), Cancer Treatment and Pharmacology (10 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Hematology (636 citations), Oncology (815 citations), Genetics (218 citations), Biological Psychiatry (50 citations) and Molecular Biology (1.2k citations). Elizabeth O’Donnell has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Noopur Raje, L. V. B. Nicholson, Andrew J. Yee, Ari Sadanandom, Clarke R. Slater, Gavin Falkous, Lucio Conti, Peter Dominy, Benjamin Schwessinger and Gillian Price. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Annals of Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.